Atria's Q2 EBIT of EUR 17.6m came in above LSEG Data & Analytics consensus expectations despite temp...
Redeye notes that Sivers’ Q2 2025 report confirms the company’s solid underlying development, with 4...
Fiskars' Q2 adjusted EBIT fell clearly short of Modular Finance consensus expectations, despite the ...
Redeye retains its positive view of Vertiseit following the Q2 report.
Redeye comments on CombinedX’s Q2 report, showing negative growth and lower margins than expected.
Q2: better momentum for the largest brands In Q1, Boråstapeter returned to organic growth.
Softer across the board The Q2 report was softer than we had expected with regard to all key line it...
Exitmarknaderna har vaknat till liv igen och VEF har använt del av likviden från årets tre exits til...
Atria reported Q2 adjusted EBIT of EUR 17.6m, 7% above LSEG Data & Analytics consensus.
Redeye comments on Avensia’s Q2 report, with sales and EBIT somewhat lower than anticipated.
US decision-making could have been delayed in Q2 During times of global uncertainty, consulting proj...
Redeye comments on OncoZenge’s recent amendment to its licensing agreement with Molteni Farmaceutici...
Redeye shares its initial thoughts on CTEK’s Q2 report, which we think came in slightly softer than ...
Hansa is better positioned to support its main value drivers, engage in strategic priorities, and po...
Atria announced today that it will proceed with EUR 82m investment in the modernisation of convenien...
Redeye sees a soft Q2 report from Stille, marked by headwinds in the surgical instruments business, ...
Redeye states that the Q2 report came in broadly in line with our expectations, with a high YoY net ...
Q2 in brief: report in line, good gross margin Embellence Group's Q2 report is in line overall.
Finnair’s Q2 proved another weak quarter due to large costs of industrial action and the North Atlan...
Redeye provides its first take on Camurus’ Q2 report 2025, published this morning.
